Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 9, 2024 $4.20 +30.59% $2.94 X 56.98% 0
Dec 9, 2024 $3.84 +19.12% $2.94 X 69.54% 0
Dec 9, 2024 Bullish $2.94 X 0
Nov 26, 2024 $5.95 +38.36% $3.83 X 44.46% 0
Nov 26, 2024 $5.33 +23.93% $3.83 X 60.68% 0
Nov 1, 2024 $26.51 +2.73% $26.21 V 98.84% 2
Nov 1, 2024 $26.25 +1.70% $26.21 V 99.86% 6
Nov 1, 2024 Bullish $26.21 V 1
Oct 17, 2024 $29.03 -2.04% $29.58 V 98.14% 1
Oct 17, 2024 $28.66 -3.27% $29.58 V 96.91% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE